DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has ...

In December 2022, the American College of Medical Genetics and Genomics made a recommendation that all expectant mothers should be offered non-invasive prenatal testing (NIPT) instead of traditional ...

SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Stand Up for APA, a nonprofit working to ensure that women of every background, race, ethnicity, and socioeconomic status in the United States receive access ...

In this interview, NewsMedical speaks with Iris Meng, Foetal Medicine Specialist at the Shanghai First Maternity and Infant Hospital in Shanghai, China, about the applications of non-invasive prenatal ...

SAN DIEGO, Sept. 9, 2020 /PRNewswire/ -- Stand Up for APA, a nonprofit working to ensure that all women in the United States receive access to the most accurate non-invasive prenatal testing (NIPT) ...

Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The "U.S. Non-Invasive Prenatal Testing Market Demand Analysis & Opportunity Evaluation, 2019-2027" report has been added to ResearchAndMarkets.com's offering ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Analysis, Market Size, Test Analysis, Country Outlook, Growth Potential, ...

A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum ...

The birth of every new life is to be celebrated. During the first trimester of pregnancy, doctors from the department of gynecology and obstetrics may suggest pregnant mothers undertake noninvasive ...

Non-invasive prenatal testing (NIPT) on pregnant women to detect the risk of a fetus having rare genetic abnormalities may often be wrong, according to recent reports. These tests, according to ...

Nearly 100 Republican legislators are demanding answers from the Food and Drug Administration (FDA) on the nature and validity of non-invasive prenatal testing (NIPT). Rep. Chip Roy, R-Texas, Sen.